Showing 1 - 6 results of 6 for search 'Monika Brunner-Weinzierl', query time: 0.03s Refine Results
  1. 1
    Potential of Point-of-Care and At-Home Assessment of Immune Status via Rapid Cytokine Detection and Questionnaire-Based Anamnesis

    Potential of Point-of-Care and At-Home Assessment of Immune Status via Rapid Cytokine Detection and Questionnaire-Based Anamnesis by Noor Jamaludeen, Christian Beyer, Ulrike Billing, Katrin Vogel, Monika Brunner-Weinzierl, Myra Spiliopoulou

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Assessment of Immune Status Using Inexpensive Cytokines: A Literature Review and Learning Approaches

    Assessment of Immune Status Using Inexpensive Cytokines: A Literature Review and Learning Approaches by Noor Jamaludeen, Juliane Lehmann, Christian Beyer, Katrin Vogel, Mandy Pierau, Monika Brunner-Weinzierl, Myra Spiliopoulou

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection

    Long-term increase in soluble interleukin-6 receptor levels in convalescents after mild COVID-19 infection by Juliane Lokau, Juliane Lokau, Yvonne Garbers, Manuel M. Vicente, Anna Dittrich, Stefan Meltendorf, Holger Lingel, Anja K. Münster-Kühnel, Monika Brunner-Weinzierl, Christoph Garbers, Christoph Garbers

    Published 2025-01-01
    Get full text
    Article
  4. 4
    Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation

    Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation by Simon Zenke, Mauricio P. Sica, Florian Steinberg, Julia Braun, Alicia Zink, Alina Gavrilov, Alexander Hilger, Aditya Arra, Monika Brunner-Weinzierl, Roland Elling, Niklas Beyersdorf, Tim Lämmermann, Cristian R. Smulski, Jan C. Rohr

    Published 2022-10-01
    Get full text
    Article
  5. 5
    Clinically relevant doses of FLT3-kinase inhibitors quizartinib and midostaurin do not impair T-cell reactivity and function

    Clinically relevant doses of FLT3-kinase inhibitors quizartinib and midostaurin do not impair T-cell reactivity and function by Denise Wolleschak, Thomas S. Mack, Florian Perner, Stephanie Frey, Tina M. Schnöder, Marie-Christine Wagner, Christine Höding, Marina C. Pils, Andreas Parkner, Stefanie Kliche, Burkhart Schraven, Katrin Hebel, Monika Brunner-Weinzierl, Satish Ranjan, Berend Isermann, Daniel B. Lipka, Thomas Fischer, Florian H. Heidel

    Published 2014-06-01
    Get full text
    Article
  6. 6
    Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells

    Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells by Satish Ranjan, Alexander Goihl, Shrey Kohli, Ihsan Gadi, Mandy Pierau, Khurrum Shahzad, Dheerendra Gupta, Fabian Bock, Hongjie Wang, Haroon Shaikh, Thilo Kähne, Dirk Reinhold, Ute Bank, Ana C. Zenclussen, Jana Niemz, Tina M. Schnöder, Monika Brunner-Weinzierl, Thomas Fischer, Thomas Kalinski, Burkhart Schraven, Thomas Luft, Jochen Huehn, Michael Naumann, Florian H. Heidel, Berend Isermann

    Published 2017-08-01
    Get full text
    Article

Search Tools: